Logo image of ALHUN.PA

HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

EPA:ALHUN - Euronext Paris - Matif - FR0014007LQ2 - Common Stock - Currency: EUR

10  0 (0%)

Fundamental Rating

4

Taking everything into account, ALHUN scores 4 out of 10 in our fundamental rating. ALHUN was compared to 53 industry peers in the Specialty Retail industry. ALHUN has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALHUN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ALHUN was profitable.
In the past year ALHUN has reported a negative cash flow from operations.
In the past 5 years ALHUN has always been profitable.
Of the past 5 years ALHUN 4 years had a positive operating cash flow.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

The Return On Assets of ALHUN (1.91%) is better than 60.38% of its industry peers.
ALHUN has a better Return On Equity (6.43%) than 62.26% of its industry peers.
ALHUN has a Return On Invested Capital of 5.48%. This is in the better half of the industry: ALHUN outperforms 66.04% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALHUN is in line with the industry average of 9.00%.
The last Return On Invested Capital (5.48%) for ALHUN is well below the 3 year average (9.61%), which needs to be investigated, but indicates that ALHUN had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROIC 5.48%
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

ALHUN's Profit Margin of 1.41% is fine compared to the rest of the industry. ALHUN outperforms 62.26% of its industry peers.
In the last couple of years the Profit Margin of ALHUN has declined.
The Operating Margin of ALHUN (2.48%) is better than 60.38% of its industry peers.
ALHUN's Operating Margin has declined in the last couple of years.
ALHUN's Gross Margin of 19.89% is on the low side compared to the rest of the industry. ALHUN is outperformed by 77.36% of its industry peers.
In the last couple of years the Gross Margin of ALHUN has grown nicely.
Industry RankSector Rank
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

ALHUN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
ALHUN has more shares outstanding than it did 5 years ago.
ALHUN has a worse debt/assets ratio than last year.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.39 indicates that ALHUN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALHUN has a Altman-Z score of 2.39. This is in the better half of the industry: ALHUN outperforms 66.04% of its industry peers.
ALHUN has a Debt/Equity ratio of 0.71. This is a neutral value indicating ALHUN is somewhat dependend on debt financing.
The Debt to Equity ratio of ALHUN (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACC0.84
WACC6.53%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.66 indicates that ALHUN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.66, ALHUN is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
ALHUN has a Quick Ratio of 1.66. This is a bad value and indicates that ALHUN is not financially healthy enough and could expect problems in meeting its short term obligations.
ALHUN has a worse Quick ratio (0.46) than 60.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.46
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

ALHUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.70%.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
Looking at the last year, ALHUN shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
Measured over the past years, ALHUN shows a very strong growth in Revenue. The Revenue has been growing by 26.45% on average per year.
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%

3.2 Future

The Earnings Per Share is expected to grow by 18.72% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.16% on average over the next years.
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5YN/A
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.83, the valuation of ALHUN can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ALHUN indicates a somewhat cheap valuation: ALHUN is cheaper than 73.58% of the companies listed in the same industry.
ALHUN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.43.
A Price/Forward Earnings ratio of 12.14 indicates a correct valuation of ALHUN.
Based on the Price/Forward Earnings ratio, ALHUN is valued cheaply inside the industry as 81.13% of the companies are valued more expensively.
ALHUN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.83
Fwd PE 12.14
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALHUN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.96
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHUN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ALHUN may justify a higher PE ratio.
A more expensive valuation may be justified as ALHUN's earnings are expected to grow with 18.72% in the coming years.
PEG (NY)2.36
PEG (5Y)N/A
EPS Next 2Y20.66%
EPS Next 3Y18.72%

More info and screens

0

5. Dividend

5.1 Amount

ALHUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUNYVERS SACA

EPA:ALHUN (6/4/2025, 7:00:00 PM)

10

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.7%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap38.70M
Analysts88
Price Target14.43 (44.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 20.83
Fwd PE 12.14
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 2.43
EV/EBITDA 13.96
EPS(TTM)0.48
EY4.8%
EPS(NY)0.82
Fwd EY8.24%
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS33.68
BVpS7.38
TBVpS4.12
PEG (NY)2.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROCE 6.65%
ROIC 5.48%
ROICexc 6.59%
ROICexgc 9.48%
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
FCFM N/A
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ROICexc(3y)11.28%
ROICexc(5y)11.76%
ROICexgc(3y)15.77%
ROICexgc(5y)16.95%
ROCE(3y)12.12%
ROCE(5y)10.83%
ROICexcg growth 3Y-40.67%
ROICexcg growth 5YN/A
ROICexc growth 3Y-38.4%
ROICexc growth 5YN/A
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 5.16
Cap/Depr 114.18%
Cap/Sales 0.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.46
Altman-Z 2.39
F-Score4
WACC6.53%
ROIC/WACC0.84
Cap/Depr(3y)138.87%
Cap/Depr(5y)108.48%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5YN/A
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5YN/A
EBIT growth 1Y-40.5%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year42.55%
EBIT Next 3Y22.31%
EBIT Next 5YN/A
FCF growth 1Y-2895.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.17%
OCF growth 3YN/A
OCF growth 5YN/A